Expert interviews
Primaryformulation expert interviews
Ask the formulators
Experts flagged formulations in development that may be sensitive to oxygen and other parameters.
Case Study · Pipeline Risk Assessment
Preparing containers for tomorrow’s drugs.
A global medical device manufacturer wanted to know how drugs reaching the market in 3 to 15 years might interact with oxygen inside its containers. Prescouter ran multiple rounds of expert interviews and pinpointed sensitive drug classes, additives and formats.
The Client
The client is a global medical device manufacturer whose products include drug containers. It wanted to understand the physicochemical sensitivities of drugs and formulations coming to market over the next 3 to 15 years.
The Challenge
New drugs.
New sensitivities.
The client needed to understand the risks of oxygen interaction, and any other stability challenges, that new and upcoming drug formulations could face within its container products.
-
Oxygen
Oxidation risk
Which drugs are most sensitive.
-
Stability
Other parameters
Physicochemical risks beyond oxygen.
-
Horizon
3 to 15 years
Drugs still in development.
Our Approach
Expert interviews, round after round.
Risk mapping
3-15year pipeline horizon
Map the sensitivities
We identified drug classes prone to oxidation and the oxygen-sensitive additives in their formulations.
Deep dive
ADConcology deep-dive focus
Go deeper on ADCs
Further interview rounds clarified how ADC storage and administration preferences shape formulation.
The Outcome
A clearer view of oxygen risk.
Prescouter identified drug classes potentially sensitive to oxidation and showed how oxygen-sensitive adjuvants and additives can affect formulations. Deep-dive interviews on oncology ADCs clarified how storage format (lyophilized or liquid) and route of administration (IV or subcutaneous) influence formulation choices.
-
Risk
Oxidation-prone classes
Drug classes to watch.
-
Formulation
Additive effects
Oxygen-sensitive adjuvants and additives.
-
Focus
Oncology ADCs
Storage and administration trends.
A container is part of the formulation whether anyone designs it that way or not. Anticipating what tomorrow’s drugs need keeps packaging from becoming the weak link.
Let’s Talk
Is your packaging ready for the next pipeline?
Anticipate how emerging drug formulations will challenge your products, with insight straight from formulation experts. Wherever you’re starting from, we’ll help you get there.
Or email [email protected]